Results 101 to 110 of about 17,470 (216)

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation [PDF]

open access: yes, 2015
Attenuated yellow fever (YF) virus 17D/17DD vaccines are the only available protection from YF infection, which remains a significant source of morbidity and mortality in the tropical areas of the world.
August, JT   +11 more
core   +1 more source

Vaccine [PDF]

open access: yes
BackgroundIn March 2009, the U.S. Food and Drug Administration licensed an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [Ixiaro]) for use in adults. The vaccine was licensed based on clinical trial safety data in 3558 JE-VC

core  

Mitigating the risk of Zika virus contamination of raw materials and cell lines in the manufacture of biologicals [PDF]

open access: yes, 2018
Ensuring the virological safety of biologicals is challenging due to the risk of viral contamination of raw materials and cell banks, and exposure during in-process handling to known and/or emerging viral pathogens.
Armstrong, Alison A.   +6 more
core   +1 more source

Jaapani entsefaliit [PDF]

open access: yes, 2013
Jaapani entsefaliidi viirus ( JEV) isoleeriti 1935. aastal Jaapanis, kuid suviseid haiguspuhanguid oli seal kirjeldatud juba 19. sajandil (1). Vaktsiini väljatöötamine 1960ndatel peaaegu kõrvaldas Jaapani entsefaliidi ( JE) Koreas, Jaapanis ja Taiwanis ...
Lindmäe, Kaspar
core   +2 more sources

Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China

open access: yesInternational Journal of Infectious Diseases, 2016
Japanese encephalitis (JE) is one of the most severe kinds of viral encephalitis and is prevalent in Asia and the Western Pacific. In China, JE was first reported in the 1940s and became the main cause of viral encephalitis, including in the Guangxi ...
Yan Yang   +3 more
doaj   +1 more source

Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.

open access: yesPLoS Neglected Tropical Diseases, 2019
Genotype III (GIII) Japanese encephalitis virus (JEV) predominance has gradually been replaced by genotype I (GI) over the last 20 years in many Asian countries.
Jianchao Wei   +12 more
doaj   +1 more source

Guillain-Barre syndrome (GBS) [PDF]

open access: yes, 2013
A 57-year-old Caucasian gentleman presented with bilateral progressive distal upper limb paraesthesiae, which he described as a feeling of “heaviness” followed by distal lower limb and mild tongue parasthaesia.
Grima, Maria Angela
core  

Investigating Nonspecific Effects of the Live-Attenuated Japanese Encephalitis Vaccine on Lower Respiratory Tract Infections in Children Aged 25-35 Months: Retrospective Cohort Study

open access: yesJMIR Public Health and Surveillance
BackgroundLive attenuated vaccines may be used to prevent nontargeted diseases such as lower respiratory tract infections (LRTIs) due to their nonspecific effects (NSEs).
Siyi Zhan   +5 more
doaj   +1 more source

Mission to Indonesia to participate to the 1st Indonesia- France Seminar in Medicine & Public Health and investigate potential collaborations on animal health : 2nd - 9th of November 2012 [PDF]

open access: yes, 2012
Emerging and zoonotic infectious diseases are a major issue in Indonesia. The objective of this mission, funded by the Institut Français d'Indonésie (IFI), was to identify potential subjects of collaboration between CIRAD, Pasteur Institute, and ...
Bourhy, Hervé   +2 more
core  

Home - About - Disclaimer - Privacy